BRK-B vs MSDL
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
MSDL presents a classic 'yield trap' profile, characterized by a stable but mediocre Piotroski F-Score of 4/9 and a critical lack of earnings growth. While the stock trades at a discount to book value (P/B 0.74) and below its Graham Number ($25.26), these value metrics are undermined by a catastrophic dividend payout ratio of 142.86% and a 43% year-over-year collapse in earnings. The technical trend is completely bearish (0/100), and the intrinsic value of $9.80 suggests the current price is unsupported by fundamental growth.
Compare Another Pair
Related Comparisons
BRK-B vs MSDL: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Morgan Stanley Direct Lending Fund (MSDL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.